Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PROPYLTHIOURACIL Cause Product use issue? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Product use issue have been filed in association with PROPYLTHIOURACIL (Propylthiouracil). This represents 1.9% of all adverse event reports for PROPYLTHIOURACIL.

18
Reports of Product use issue with PROPYLTHIOURACIL
1.9%
of all PROPYLTHIOURACIL reports
0
Deaths
7
Hospitalizations

How Dangerous Is Product use issue From PROPYLTHIOURACIL?

Of the 18 reports, 7 (38.9%) required hospitalization, and 4 (22.2%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PROPYLTHIOURACIL. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does PROPYLTHIOURACIL Cause?

Drug ineffective (121) Foetal exposure during pregnancy (110) Anti-neutrophil cytoplasmic antibody positive vasculitis (81) Exposure during pregnancy (75) Hyperthyroidism (58) Off label use (54) Maternal exposure during pregnancy (50) Agranulocytosis (42) Vasculitis (41) Premature baby (38)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which PROPYLTHIOURACIL Alternatives Have Lower Product use issue Risk?

PROPYLTHIOURACIL vs PROTAMINE PROPYLTHIOURACIL vs PROTHIPENDYL PROPYLTHIOURACIL vs PROTIONAMIDE PROPYLTHIOURACIL vs PROTONIX PROPYLTHIOURACIL vs PROTOPIC

Related Pages

PROPYLTHIOURACIL Full Profile All Product use issue Reports All Drugs Causing Product use issue PROPYLTHIOURACIL Demographics